Ergot alkaloid control in biotechnological processes and pharmaceuticals (a mini review).

IF 3.6 Q2 TOXICOLOGY
Frontiers in toxicology Pub Date : 2024-10-08 eCollection Date: 2024-01-01 DOI:10.3389/ftox.2024.1463758
A Volnin, A Parshikov, N Tsybulko, P Mizina, N Sidelnikov
{"title":"Ergot alkaloid control in biotechnological processes and pharmaceuticals (a mini review).","authors":"A Volnin, A Parshikov, N Tsybulko, P Mizina, N Sidelnikov","doi":"10.3389/ftox.2024.1463758","DOIUrl":null,"url":null,"abstract":"<p><p>The control of ergot alkaloids in biotechnological processes is important in the context of obtaining new strain producers and studying the mechanisms of the biosynthesis, accumulation and secretion of alkaloids and the manufacturing of alkaloids. In pharmaceuticals, it is important to analyze the purity of raw materials, especially those capable of racemization, quality control of dosage forms and bulk drugs, stability during storage, etc. This review describes the methods used for qualitative and quantitative chemical analysis of ergot alkaloids in tablets and pharmaceutic forms, liquid cultural media and mycelia from submerged cultures of ergot and other organisms producing ergoalkaloid, sclerotias of industrial <i>Claviceps spp</i>. parasitic strains. We reviewed analytical approaches for the determination of ergopeptines (including their dihydro- and bromine derivatives) and semisynthetic ergot-derived medicines such as cabergoline, necergoline and pergolide, including precursors for their synthesis. Over the last few decades, strategies and approaches for the analysis of ergoalkaloids for medical use have changed, but the general principles and objectives have remained the same as before. These changes are related to the development of new genetically improved strains producing ergoalkaloids and the development of technologies for the online control of biotechnological processes and pharmaceutical manufacturing (\"process analytical technologies,\" PAT). Overall, the industry is moving toward \"smart manufacturing.\" The development of approaches to production cost estimation and product quality management, manufacturing management, increasing profitability and reducing the negative impact on personnel and the environment are integral components of sustainable development. Analytical approaches for the analysis of ergot alkaloids in pharmaceutical raw materials should have high enough specificity for the separation of dihydro derivatives, enantiomers and R-S epimers of alkaloids, but low values of the quantitative detection limit are less frequently needed. In terms of methodology, detection methods based on mass spectrometry have become more developed and widespread, but NMR analysis remains in demand because of its high accuracy and specificity. Both rapid methods and liquid chromatography remain in demand in routine practice, with rapid analysis evolving toward higher accuracy owing to improved analytical performance and new equipment. New composite electrochemical sensors (including disposable sensors) have demonstrated potential for real-time process control.</p>","PeriodicalId":73111,"journal":{"name":"Frontiers in toxicology","volume":"6 ","pages":"1463758"},"PeriodicalIF":3.6000,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11493748/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in toxicology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/ftox.2024.1463758","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The control of ergot alkaloids in biotechnological processes is important in the context of obtaining new strain producers and studying the mechanisms of the biosynthesis, accumulation and secretion of alkaloids and the manufacturing of alkaloids. In pharmaceuticals, it is important to analyze the purity of raw materials, especially those capable of racemization, quality control of dosage forms and bulk drugs, stability during storage, etc. This review describes the methods used for qualitative and quantitative chemical analysis of ergot alkaloids in tablets and pharmaceutic forms, liquid cultural media and mycelia from submerged cultures of ergot and other organisms producing ergoalkaloid, sclerotias of industrial Claviceps spp. parasitic strains. We reviewed analytical approaches for the determination of ergopeptines (including their dihydro- and bromine derivatives) and semisynthetic ergot-derived medicines such as cabergoline, necergoline and pergolide, including precursors for their synthesis. Over the last few decades, strategies and approaches for the analysis of ergoalkaloids for medical use have changed, but the general principles and objectives have remained the same as before. These changes are related to the development of new genetically improved strains producing ergoalkaloids and the development of technologies for the online control of biotechnological processes and pharmaceutical manufacturing ("process analytical technologies," PAT). Overall, the industry is moving toward "smart manufacturing." The development of approaches to production cost estimation and product quality management, manufacturing management, increasing profitability and reducing the negative impact on personnel and the environment are integral components of sustainable development. Analytical approaches for the analysis of ergot alkaloids in pharmaceutical raw materials should have high enough specificity for the separation of dihydro derivatives, enantiomers and R-S epimers of alkaloids, but low values of the quantitative detection limit are less frequently needed. In terms of methodology, detection methods based on mass spectrometry have become more developed and widespread, but NMR analysis remains in demand because of its high accuracy and specificity. Both rapid methods and liquid chromatography remain in demand in routine practice, with rapid analysis evolving toward higher accuracy owing to improved analytical performance and new equipment. New composite electrochemical sensors (including disposable sensors) have demonstrated potential for real-time process control.

生物技术工艺和制药中的麦角生物碱控制(小型综述)。
在生物技术过程中对麦角生物碱的控制,对于获得新的菌株生产者、研究生物碱的生物合成、积累和分泌机制以及生物碱的制造都很重要。在制药方面,分析原料的纯度(尤其是那些可能发生外消旋化的原料)、剂型和散装药物的质量控制、储存期间的稳定性等都非常重要。本综述介绍了片剂和药剂、液体培养基和麦角沉水培养菌丝体中麦角生物碱的定性和定量化学分析方法,以及麦角和其他产生麦角生物碱的生物、Claviceps spp.工业寄生菌株的硬菌的定性和定量化学分析方法。我们回顾了测定麦角肽(包括其二氢衍生物和溴衍生物)和半合成麦角衍生药物(如卡麦角林、新麦角林和培高利特)(包括其合成前体)的分析方法。在过去的几十年中,用于医疗用途的麦角生物碱分析策略和方法发生了变化,但总体原则和目标仍与以前相同。这些变化与生产麦角碱的新基因改良菌株的开发以及生物技术过程和药品生产在线控制技术("过程分析技术",PAT)的开发有关。总体而言,该行业正朝着 "智能制造 "的方向发展。开发生产成本估算和产品质量管理、生产管理、提高盈利能力以及减少对人员和环境的负面影响的方法是可持续发展不可或缺的组成部分。分析制药原料中麦角生物碱的分析方法应具有足够高的特异性,以分离生物碱的二氢衍生物、对映体和 R-S 表聚体,但较少需要低值的定量检测限。在方法学方面,基于质谱的检测方法已经越来越发达和普及,但核磁共振分析因其高精度和特异性而仍然很受欢迎。快速分析法和液相色谱法在日常实践中仍有需求,由于分析性能的提高和新设备的出现,快速分析法正朝着更高精度的方向发展。新型复合电化学传感器(包括一次性传感器)已显示出实时过程控制的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.80
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信